Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Drugs: Coronavirus

Department of Health and Social Care written question – answered on 24th June 2020.

Alert me about debates like this

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

Holding answer received on 02 June 2020

The pursuit of safe and effective COVID-19 treatments is a cross-Government effort from people in UK Research and Innovation looking at early stage research and development, to those in the National Institute for Health Research supporting clinical trials, and the Department of Health and Social Care, the Department for Business, Energy and Industrial Strategy, Public Health England (PHE) and NHS England overseeing medicine supply, manufacturing and procurement strategies.

The Therapeutics Taskforce is driving forward, expediting and co-ordinating efforts to research, produce and distribute safe and effective COVID-19 treatments to patients as soon as possible.

We estimate that there are at least 50 civil servants (27.4 full-time equivalents) working across the Department of Health and Social Care, the Department for Business, Energy and Industrial Strategy and PHE on the development and deployment of treatments for COVID-19. It is not possible to segregate this figure for anti-viral drugs only.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.